Who BioHorizons is

BioHorizons is a U.S. dental implant and tissue-regeneration company founded in 1994 from research associated with the University of Alabama at Birmingham. The company states that its implants are manufactured in the United States and that it operates in more than 90 countries. This scale supports its international reputation, but company size alone does not determine a patient’s outcome.

What makes the system recognizable

BioHorizons offers tapered implant designs, restorative components and digital options. Its best-known differentiator is Laser-Lok: precision laser-machined microchannels on selected implant or abutment collars. The intended biological concept is to influence soft-tissue organization and help maintain crestal tissues around the implant.

What independent evidence says

Systematic reviews of laser-microtextured collars have reported less marginal bone loss and shallower probing depths than machined collars in several comparisons. However, reviews also report heterogeneity between studies, and they have not consistently shown a statistically significant improvement in implant survival compared with other collar surfaces. This is a promising tissue-management feature—not a guarantee.

Success rates need context

There is no scientifically honest single “BioHorizons success rate” for every patient and procedure. One meta-analysis of laser-microtextured collars reported an overall survival estimate around 97% across the included studies, while another found no significant failure-rate advantage over machined collars. Results depend on study length, indication, patient health, bone and soft tissue, loading, restoration design, hygiene and maintenance.

Regulation and global standing

BioHorizons implant systems have U.S. FDA 510(k) records for specified indications and configurations. FDA clearance, published research, a three-decade company history and international distribution are meaningful credibility signals. They should not be presented as proof that one brand is universally superior to all alternatives.

The brand is one part of the plan

A reliable implant system gives the clinical team a validated range of implants, components and protocols. Long-term care still depends on correct diagnosis, prosthetically driven positioning, surgical execution, soft-tissue management, a cleanable restoration and regular maintenance. The best system is the one appropriately selected and competently used for the individual case.

Dr. Shatat and BioHorizons

Dr. Mohamad Shatat serves as an international speaker for BioHorizons, sharing education that connects implant science, digital planning and clinical application. This professional role supports education and product familiarity; it does not replace individual diagnosis or justify choosing a system without case-specific reasons.

References and sources

Sources were selected from scientific bodies, regulatory records and peer-reviewed reviews. Links are provided so context and findings can be checked.